Effects of glucosamine hydrochloride and chondroitin sulphate, alone and in combination, on normal and interleukin-1 conditioned equine articular cartilage explant metabolism

Equine Veterinary Journal

Volumn 37, Issue 3, 2005, Pages 227-231

  Dechant, J E ^a,b   Baxter, G M ^a   Frisbie, D D ^a   Trotter, G W ^a   McIlwraith, C W ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Articular cartilage; Chondroitin sulphate; Glucosamine; Horse; Osteoarthritis

Indexed keywords

CHONDROITIN SULFATE; GLUCOSAMINE; GLYCOSAMINOGLYCAN; INTERLEUKIN 1;

ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG MEGADOSE; EXPLANT; FEMUR; GLYCOSAMINOGLYCAN METABOLISM; LOW DRUG DOSE; NONHUMAN;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 18544382490     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/0425164054530687     Document Type: Article

References (45)

1. Adebowale, A., Du, J., Liang, Z., Leslie, J.L. and Eddington, N.D. (2002) The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulphate after single and multiple doses to beagle dogs. Biopharm. Drug Dispos. 23, 217-225.
2. Anderson, C.C., Cook, J.L., Kreeger, J.M., Tomlinson, J.L. and Wagner-Mann, C.C. (1999) In vitro effects of glucosamine and acetylsalicylate on canine chondrocytes in 3-dimensional culture. Am. J. vet. Res. 60, 1546-1551.
3. Anon (1990) SAS/Stat User's Guide: Statistics, 4th edn., SAS Institute Inc., Cary. pp 891-996.
4. Bassleer, C., Combal, J.P., Bougaret, S. and Malaise, M. (1998a) Effects of chondroitin sulphate and interleukin-1β (beta) on human articular chondrocytes cultivated in clusters. Osteoarthritis Cartilage 6, 196-204.
5. Bassleer, C., Rovatti, L. and Franchimoni, P. (1998b) Stimulation of proteoglycan production by glucosamine sulphate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage 6, 427-434.
6. Bruyere, O., Honore, A., Ethgen, O., Rovati, L.C., Giacovelli, G., Henroitin, Y.E., Seidel, L. and Reginster, J.Y.L. (2003) Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulphate. Osteoarthritis Cartilage 11, 1-5.
7. Byron, C.R., Orth, M.W., Venta, P.J., Lloyd, J.W. and Caron, J.P. (2003) Influence of glucosamine on matrix metalloproteinase expression and activity in lipopolysaccharide-stimulatedequine chondrocytes. Am. J. vet. Res. 64, 666-671.
8. Calabrese, E.J. and Baldwin, L.A. (2003) Hormesis: the dose-response revolution. Ann. Rev. Pharmacol. Toxicol. 43, 175-197.
9. Das, A. and Hammad, T.A. (2000) Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulphate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage 8, 343-350.
10. Davidson, G. (2000) Glucosamine and chondroitin sulphate. Comp. cont. Educ. pract. Vet. 22, 454-458.
11. De Mattei, M., Pellati, A., Pasello, M., de Terlizzi, F., Massari, L., Gemmati, D. and Caruso, A. (2002) High doses of glucosamine-HCl have detrimental effects on bovine articular cartilage explants cultured in vitro. Osteoarthritis Cartilage 10, 816-825.
12. Dechant, J.E., Baxter, G.M., Frisbie, D.D., Trotter, G.W. and McIlwraith, C.W. (2003) Effects of dosage titration of methylprednisolone acetate and triamcinolone acetonide on interleukin 1-conditioned equine articular cartilage explants in vitro. Equine vet. J. 35, 444-450.
13. Dodge, G.R., Regatte, R.R., Hall, J.O., Borthakur, A., Sarma, A.V., Callaway, D.A. and Reddf, R. (2001) The fate of oral glucosamine traced by 13C-labelling in the dog. Osteoarthritis Cartilage 9, S41.
14. Du, J., White, N. and Eddingon, N.D. (2004) The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulphate after oral and intravenous single dose administration in the horse. Biopharm. Drug Dispos. 25, 109-116.
15. Eddington, N.D., Du, J. and White, N. (2001) Evidence of the oral absorption of chondroitin sulphate as determined by total disaccharide content after oral and intravenous administration to horses. Proc. Am. Ass. equine Practnrs. 47, 326-328.
16. Farndale, R.W., Sayers, C.A. and Barrett, A.J. (1982) A direct spectrophotometric microassay for sulphated glycosaminoglycans in cartilage cultures. Connect. Tissue Res. 9, 247-248.
17. Fenton, J.I., Chlebek-Brown, K.A., Caron, J.P. and Orth, M.W. (2002) Effect of glucosamine on interleukin-1-conditioned articular cartilage. Equine vet. J., Suppl. 34, 219-223.
18. Fenton, J.I., Chlebek-Brown, K.A., Peters, T.L., Caron, J.P. and Orth, M.W. (2000) Glucosamine HCl reduces equine articular cartilage degradation in explant culture. Osteoarthritis Cartilage 8, 258-265.
19. Frisbie, D.D., Kawcak, C.E., Trotter, G.W. and McIlwraith, C.W. (1998) The assessment of chondrocyte proteoglycan metabolism using molecular sieve column chromatography as compared to three commonly utilized techniques. Osteoarthritis Cartilage 6, 137-145.
20. Frisbie, D.D., Sandler, E.A., Trotter, G.W. and McIlwraith, C.W. (2000) Metabolic and mitogenic activities of insulin-like growth factor-1 in interleukin-1-conditioned equine cartilage. Am. J. vet. Res. 61, 436-441.
21. Glade, M.J. (1990) Polysulphated glycosaminoglycan accelerates net synthesis of collagen and glycosaminoglycans by arthritic equine cartilage tissue and chondrocytes. Am. J. vet. Res. 51, 779-785.
22. Grande, D.A., O'Grady, C., Garone, E., Lippiello, L. and Marwin, S. (2000) Chondroprotective and gene expression effects of nutritional supplements on articular cartilage. Osteoarthritis Cartilage 8, S34-S35.
23. Gouze, J.N., Bianchi, A., Becuwe, P., Dauca, M., Netter, P., Magdalou, J., Terlain, B. and Bordji, K. (2002) Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-κB pathway. FEBS Letters 510, 166-170.
24. Hanson, R.R., Brawner, W.R., Blaik, M.A., Hammad, T.A., Kincaid, S.A. and Pugh, D.G. (2001) Oral treatment with a nutraceutical (Cosequin) for ameliorating signs of navicular syndrome in horses. Vet. Ther. 2, 148-159.
25. Hanson, R.R., Smalley, L.R., Huff, G.K., White, S. and Hammad, T.A. (1997) Oral treatment with a glucosamine-chondroitin sulphate compound for degenerative joint disease in horses: 25 cases. Equine Pract. 19, 16-22.
26. Largo, R., Alvarez-Soria, M.A., Diez-Ortego, I., Clavo, E., Sanchez-Pernaute, O., Edigo, J. and Herrero-Beaumont, G. (2003) Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes. Osteoarihritis Cartilage 11, 290-298.
27. Lippiello, L. (2003) Glucosamine and chondroitin sulphate: biological response modifiers of chondrocytes under simulated conditions of joint stress. Osteoarthritis Cartilage 11, 335-342.
28. Lippiello, L., Han, M.S. and Henderson, T. (2002) Protective effect of the chondroprotective agent Cosequin DS on bovine articular cartilage exposed in vitro to nonsteroidal anti-inflammatory agents. Vet. Ther. 2, 128-135.
29. Lippiello, L., Woodward, J., Karpman, R. and Hammad, T.A. (2000) In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulphate. Clin. Orthop. Rel. Res. 381, 229-240.
30. MacDonald, M.H., Stover, S.M., Willits, N.H. and Benton, H.D. (1992) Regulation of matrix metabolism in equine cartilage explant cultures by interleukin-1. Am. J. vet. Res. 53, 2278-2285.
31. Masuda, K., Shirota, H. and Thonar, E. (1994) Quantification of 35S-labeled proteoglycans complexed to alcian blue by rapid filtration in multiwell plates. Anal. Biochem. 217, 167-175.
32. McAlindon, T.E., LaValley, M.P., Gulin, J.P. and Felson, D.T. (2000) Glucosamine and chondroitin for treatment of osteoarthritis - a systematic quality assessment and meta-analysis. J. Am. vet. med. Ass. 283, 1469-1475.
33. Moreau, M., Dupuis, J., Bonneau, N.H. and Desnoyers, M. (2003) Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. Vet. Rec. 152, 323-329.
34. Mroz, P.J. and Silbert, J.E. (2003) Effects of [3H] glucosamine concentration on [3H] chondroitin sulphate formation by cultured chondrocytes. Biochem. J. 376, 511-515.
35. Nerucci, F., Fioravanti, A., Cicero, M.R., Collodel, G and Marcolongo, R. (2000) Effects of chondroitin sulphate and interleukin-1β on human chondrocyte cultures exposed to pressurization: a biochemical and morphological study. Osteoarthritis Cartilage 8, 279-287.
36. Orth, M.W., Peters, T.L. and Hawkins, J.N. (2002) Inhibition of articular cartilage degradation by glucosamine-HCl and chondroitin sulphate. Equine vet. J., Suppl. 34, 224-229.
37. Platt, D. and Bayliss, M.T. (1994) An investigation of the proteglycan metabolism of mature equine articular cartilage and its regulation by interleukin-1. Equine vet. J. 26, 297-303.
38. Reginster, J.Y., Deroisy, R., Rovati, L.C., Lee, R.L., Lejeune, E. Bruyere, O., Giacovelli, G., Henroitin, Y., Dacre, J.E. and Gossett, C. (2001) Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet 357, 251-256.
39. Richy, F., Bruyere, O., Ethgen, O., Cucherat, M., Henroitin, Y. and Reginster, J.Y. (2003) Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis. Arch. Int. Med. 163, 1514-1522.
40. Ronca, F., Palmieri, L., Panicucci, P. and Ronca, G. (1998) Anti-inflammatory activity of chondroitin sulphate. Osteoarthritis Cartilage 6, 14-21.
41. Sandler, E.A., Frisbie, D.D. and Mcllwraith, C.W. (2004) A dose titration of triamcinolone acetonide on insulin-like growth factor-1 and interleukin-1-conditioned equine cartilage explants. Equine vet. J. 36, 58-63.
42. Sandy, J.D., Gamett, D., Thompson, V. and Verscharen, C. (1998) Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. Biochem. J. 335, 59-66.
43. Setnikar, I. and Rovati, L.C. (2001) Absorption, distribution, metabolism and excretion of glucosamine sulphate. A review. Arnzeimittelforschung 51, 699-725.
44. Verbruggen, G., Goemaere, S. and Veys, E.M. (2002) Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. Clin. Rheum. 21, 231-243.
45. Wright, I.M. (2001) Oral supplement in the treatment and prevention of joint diseases: a review of their potential application to the horse. Equine vet. Educ. 3, 179-184.